person

Anders Fink-Jensen, MD

as of 2026-07-01

Monitor this Ask about this

at a glance

Roles: Principal Investigator, Author, Investigator+Author

KOL signal score 8

1 publications · 1 high-value

Synthesized from structured facts only — each point cited above.

Profile

Affiliation

Psychiatric Centre Copenhagen

Roles

Principal Investigator, Author, Investigator+Author

KOL signal

Publications

1 (1 high-value)

Trial investigator

yes

Trials led

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

NCT04892199Phase 4Active Not Recruiting

Publications & congress

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial.

Lancet (London, England) · 2026 · high-value

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

PRINCIPAL_INVESTIGATOR

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

trial